SCHEMBL8092483

SCHEMBL8092483

CCC(C)(OC(=O)/C=C/C(=O)O)C(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 10/20 0.48
GABRP O00591 2/20 0.36
GABRD O14764 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRB1 P18505 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
GABRA3 P34903 2/20 0.36
GABRA2 P47869 2/20 0.36
GABRB2 P47870 2/20 0.36
GABRA4 P48169 2/20 0.36
GABRE P78334 2/20 0.36
GABRA6 Q16445 2/20 0.36
GABRG1 Q8N1C3 2/20 0.36
GABRG3 Q99928 2/20 0.36
GABRQ Q9UN88 2/20 0.36
ALDH1A1 P00352 2/20 0.34
GAA P10253 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8092491 1.00 HCAR2 (0.48) HCAR2GABRPGABRDGABRA1GABRB1
SCHEMBL8092480 0.92 ATM (0.39) HCAR2ATMTSHRMAPT
SCHEMBL8102281 0.86 HCAR2 (0.50) HCAR2GABRPGABRDGABRA1GABRB1
SCHEMBL11747396 0.82 HCAR2 (0.52) HCAR2GABRPGABRDGABRA1GABRB1
SCHEMBL11747412 0.82 HCAR2 (0.52) HCAR2GABRPGABRDGABRA1GABRB1
SCHEMBL11749627 0.82 HCAR2 (0.52) HCAR2GABRPGABRDGABRA1GABRB1
SCHEMBL9561373 0.79 HCAR2 (0.52) HCAR2ALDH1A1ATML3MBTL1TSHR
SCHEMBL9860820 0.79 HCAR2 (0.52) HCAR2ALDH1A1ATML3MBTL1TSHR
SCHEMBL9561368 0.79 HCAR2 (0.52) HCAR2ALDH1A1ATML3MBTL1TSHR
SCHEMBL15992469 0.77 HCAR2 (0.41) HCAR2GABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150087-A NON-HEPATITIS A OR B VIRUS POLYPEPTIDE WHICH IS CAPABLE OF ILLICITING IMMUNE RESPONSE WITH HEPATITUS VIRUS ANTIBODIES, FOR THE TREATMENT OF AND PREVENTION OF VIRAL INFECTIONS CHIRON CORPORATION (US) 2000-11-21 US disclosed
EP-1006130-A1 Fumaric acid diester resin composition, cross-linked fumaric acid diester resin and process NOF CORPORATION (JP) 2000-06-07 EP disclosed
US-6031003-A TREATING A PATIENT HAVING A DISEASE OR DISORDER TREATABLE BY MODULATING ACTIVITY OF CALCIUM RECEPTORS IN VITRO BY ADMINISTERING A CALCIMIMETIC COMPOUND DETERMINED BY THE CALCILYTIC BOVINE PARATHYROID CELL TEST; OSTEOPOROSIS NPS PHARMACEUTICALS, INC. (US) 2000-02-29 US disclosed
US-6027895-A CLEAVING DNA USING NUCLEOTIDE INTEGRASE COMPRISING A GROUP II INTRON RNA WITH GROUP II INTRON-ENCODED PROTEIN BOUND THERETO; CLEAVES AT SPECIFIC SITES AND SIMULTANEOUSLY INSERTS A NEW NUCLEIC ACID MOLECULE INTO THE CLEAVAGE SITE THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2000-02-22 US disclosed
US-5981195-A HYBRID G-PROTEIN BINDING RECEPTOR SITES; DETECTING THE SITE OF ACTION OF COMPOUND ON RECEPTOR; SCREENING FOR MODULATORS OF RECEPTOR; FOR TREATMENT OF NERVOUS SYSTEM DISORDERS; MUSCLE RELAXANTS; ANALGESICS NPS PHARMACEUTICALS, INC. (US) 1999-11-09 US disclosed